Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
To compare efficacy, safety and durability of combination therapy with pioglitazone plus
GLP-1 RA versus basal bolus insulin in poorly controlled T2DM patients on metformin plus
sulfonylurea